Vanda Pharmaceuticals Inc. Common Stock Shares Outstanding

Quick Answer

Vanda Pharmaceuticals Inc. reported Common Stock Shares Outstanding of 59.10 million shares for the year ending 2025.

  • Vanda Pharmaceuticals Inc. showed an increase of +1.4% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from Vanda Pharmaceuticals Inc.'s annual report (Form 10-K), filed with the SEC on February 12, 2026.
  • XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2011: 28.10 million shares | Q3 2011: 28.11 million shares | Q1 2012: 28.23 million shares | Q2 2012: 28.23 million shares | Q3 2012: 28.23 million shares | Q1 2013: 28.35 million shares | Q2 2013: 28.48 million shares | Q3 2013: 33.19 million shares | Q1 2014: 33.87 million shares | Q2 2014: 33.88 million shares | Q3 2014: 33.90 million shares | Q1 2015: 41.79 million shares | Q2 2015: 42.27 million shares | Q3 2015: 42.82 million shares | Q1 2016: 43.11 million shares | Q2 2016: 43.28 million shares | Q3 2016: 43.93 million shares | Q1 2017: 44.55 million shares | Q2 2017: 44.85 million shares | Q3 2017: 44.92 million shares | Q1 2018: 52.11 million shares | Q2 2018: 52.38 million shares | Q3 2018: 52.40 million shares | Q1 2019: 52.96 million shares | Q2 2019: 53.26 million shares | Q3 2019: 53.33 million shares | Q1 2020: 54.13 million shares | Q2 2020: 54.63 million shares | Q3 2020: 54.69 million shares | Q1 2021: 55.56 million shares | Q2 2021: 55.63 million shares | Q3 2021: 55.71 million shares | Q1 2022: 56.49 million shares | Q2 2022: 56.55 million shares | Q3 2022: 56.59 million shares | Q1 2023: 57.44 million shares | Q2 2023: 57.50 million shares | Q3 2023: 57.53 million shares | Q1 2024: 58.20 million shares | Q2 2024: 58.29 million shares | Q3 2024: 58.31 million shares | Q1 2025: 58.93 million shares | Q2 2025: 59.08 million shares | Q3 2025: 59.10 million shares.
  • Over the full 16 years of available data (2010 to 2025), Vanda Pharmaceuticals Inc.'s Common Stock Shares Outstanding has grown by 110.8%.
  • Historical annual values: Fiscal year 2025: 59.10 million shares | Fiscal year 2024: 58.31 million shares | Fiscal year 2023: 57.53 million shares | Fiscal year 2022: 56.78 million shares | Fiscal year 2021: 55.90 million shares | Fiscal year 2020: 54.87 million shares | Fiscal year 2019: 53.55 million shares | Fiscal year 2018: 52.48 million shares | Fiscal year 2017: 44.94 million shares | Fiscal year 2016: 44.00 million shares | Fiscal year 2015: 42.82 million shares | Fiscal year 2014: 41.49 million shares | Fiscal year 2013: 33.34 million shares | Fiscal year 2012: 28.24 million shares | Fiscal year 2011: 28.12 million shares | Fiscal year 2010: 28.04 million shares.
  • Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: